BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wei ZJ, Wang L, Wang RQ, Wang Y, Chen H, Ma HL, Xu YJ. Safety and effectiveness of induction chemoimmunotherapy followed by definitive radiotherapy or concurrent chemoradiotherapy in esophageal squamous cell carcinoma. World J Clin Oncol 2025; 16(3): 101251 [PMID: 40130057 DOI: 10.5306/wjco.v16.i3.101251]
URL: https://www.wjgnet.com/2218-4333/full/v16/i3/101251.htm
Number Citing Articles
1
Wenxue Ma, Natalia Baran. Expanding horizons in esophageal squamous cell carcinoma: The promise of induction chemoimmunotherapy with radiotherapyWorld Journal of Clinical Oncology 2025; 16(7): 104959 doi: 10.5306/wjco.v16.i7.104959
2
Kai Yang, Wei Shang, Lu Wang, Jianzhong He, Zhigang Zuo, Quankai Dai, Jialing Liu, Langhong Zeng, Yuntian Yang, Fengjun Cao, Yuandong Yu, Guoxing Wan. Sex-based heterogeneity in response to first-line immunotherapy plus chemotherapy in advanced esophageal squamous-cell carcinoma: a meta-analysisFrontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1784688